文献速递临床试验与 GCP基础与转化研究

碧萝芷对创伤性脑损伤重症患者炎症标志物及营养临床状态影响的随机对照试验方案

Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol.
PubMed 文献 · Trials · 2020-02-11

本方案为双盲随机对照试验,拟在创伤性脑损伤重症患者中比较碧萝芷150 mg补充10天与安慰剂的效应。主要观察炎症标志物(IL-6、IL-1β、C反应蛋白)与氧化应激指标(丙二醛、总抗氧化能力)在基线、第5天和第10天的变化,并评估临床与营养状态、SOFA评分及28天死亡率。作者预期碧萝芷可改善临床营养状态并减轻炎症与氧化应激。

要点

  • 碧萝芷150 mg补充10天,与安慰剂对照,双盲随机分组。
  • 炎症指标于基线、第5天、第10天检测,SOFA隔日评估。
  • 主要预期为改善临床营养状态并降低炎症与氧化应激。

核心结论

  • 作者预期创伤性脑损伤重症患者补充150 mg碧萝芷10天可改善临床与营养状态并减轻炎症和氧化应激。

研究设计与样本

  • 双盲随机对照试验方案,采用区组随机化,设碧萝芷150 mg组与安慰剂组,干预10天。
  • 炎症与氧化应激指标在基线、第5天和研究结束(第10天)测量,临床与营养状态评估3次。
  • SOFA问卷隔日填写,死亡率在干预开始后28天内计算,分析按初始分组意向性治疗进行。

主要发现

  • 原文未报告试验结果,仅提出预期效应。

关键数值与推荐

  • 干预剂量为碧萝芷150 mg,疗程10天;对照为相同时长安慰剂。
  • 炎症标志物包括IL-6、IL-1β、C反应蛋白;氧化应激指标包括丙二醛、总抗氧化能力。
  • 临床与营养状态评估3次,SOFA隔日评估,死亡率统计窗口为干预开始后28天。

临床怎么用

  • 该方案为研究设计,尚不能据此形成临床用药推荐。

局限性

  • 原文为试验方案,未提供实际结果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traumatic brain injury (TBI) is one of the major health and socioeconomic problems in the world. Immune-enhancing enteral formula has been proven to significantly reduce infection rate in TBI patients. One of the ingredients that can be used in immunonutrition formulas to reduce inflammation and oxidative stress is pycnogenol. OBJECTIVE: The objective of this work is to survey the effect of pycnogenol on the clinical, nutritional, and inflammatory status of TBI patients. METHODS: This is a double-blind, randomized controlled trial. Block randomization will be used. An intervention group will receive pycnogenol supplementation of 150 mg for 10 days and a control group will receive a placebo for the same duration. Inflammatory status (IL-6, IL- 1β, C-reactive protein) and oxidative stress status (malondialdehyde, total antioxidant capacity), at the baseline, at the 5th day, and at the end of the study (10th day) will be measured. Clinical and nutritional status will be assessed three times during the intervention. The Sequential Organ Failure Assessment (SOFA) questionnaire for assessment of organ failure will be filled out every other day. The mortality rate will be calculated within 28 days of the start of the intervention. Weight, body mass index, and body composition will be measured. All analyses will be conducted by an initially assigned study arm in an intention-to-treat analysis. DISCUSSION: We expect that supplementation of 150 mg pycnogenol for 10 days will improve clinical and nutritional status and reduce the inflammation and oxidative stress of the TBI patients. TRIAL REGISTRATION: This trial is registered at clinicaltrials.gov (ref: NCT03777683) at 12/13/2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Malekahmadi M, Moradi Moghaddam O, Islam SMS, et al. Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol. Trials. 2020. PMID: 32046747. doi:10.1186/s13063-019-4008-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。